Biomedicines, Volume 10, Issue 11
2022 November - 329 articles
Cover Story: Specialized pro-resolving molecules (SPMs) are endogenous mediators destined to resolve inflammation. Each sub-class, resolvins, maresins, lipoxins, and protectins, has a complex temporal and functional interdependence with the rest, which brings about the resolution of inflammation through various pathways. These include the following: (1) increasing the effectiveness of efferocytosis, a process of clearing apoptotic cells; (2) reducing the levels of pro-inflammatory molecules such as MCP-1, VCAM-1, and leukotriene B4, which recruit inflammatory cells to the plaque site, increasing its size and instability. By restricting inflammation, SPMs reduce plaque size and increase its stability, leading to the prevention of life-threatening events in cardiovascular disease. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.